© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
News for Patients from the Journal of Clinical Oncology
Below are summaries of research advances in clinical oncology. The information presented in Cancer Advances is the same information the American Society of Clinical Oncology (ASCO) provides to cancer physicians, in consumer terms.
-
April 22, 2013
New findings from a retrospective study suggest that targeted anti-HER2 therapy may slow disease progression in patients with advanced lung cancer who carry a specific alteration in HER2—a protein that controls cancer growth and spread, found on some cancer cells, such as breast, ovarian, and lung cancer cells.
-
April 8, 2013
New findings from a clinical trial in patients with colorectal cancer and inoperable metastases in the liver (cancer that has spread from the colon or rectum to the liver) suggest that combination treatment with standard therapy and targeted drug cetuximab (Erbitux) caused significant shrinkage of metastases, making successful surgery feasible.
-
Cancer Advances: Women Who Eat More Soy Food Before Being Diagnosed With Lung Cancer May Live LongerMarch 25, 2013
Analysis of data collected in a large, population-based study in Shanghai, China, showed women who consumed higher amounts of soy food in the years leading up to their diagnosis of lung cancer lived longer. These results offer the first scientific evidence that consuming soy food before cancer diagnosis may be associated with significantly improved survival in patients with lung cancer.
-
March 4, 2013
New findings from a prospective clinical trial in children with non-hereditary retinoblastoma affecting only one eye (unilateral retinoblastoma) will help doctors identify patients who should not receive chemotherapy after surgical removal of the diseased eye.
-
November 13, 2012
A population- and health systems-based prospective study revealed that timing of end-of-life (EOL) care discussions strongly affects the intensity of care patients with advanced cancer receive near the end of life. Specifically, patients who had EOL care conversations with their doctors before the last 30 days of life were much more likely to receive hospice care and less likely to undergo “aggressive” medical care compared to those that had EOL conversations later. According to previous research, many patients who do not receive aggressive therapy at the end of life have a better quality of life in their final weeks.
-
July 30, 2012
Results of a large, population-based study support guidelines on cervical cancer screening released earlier this year, which recommend “co-testing” consisting of human papillomavirus (HPV) testing and conventional Papanicolaou (Pap) testing every five years.
-
March 12, 2012
A new, long-term study shows that survival rates for children and adolescents with acute lymphoblastic leukemia (ALL), the most common type of pediatric cancer, climbed steadily between 1990 and 2005. This analysis is the largest study to date of ALL survival, exploring important survival gains based on patient age, race, ethnicity, and subtype of ALL. The findings were published March 12 in the Journal of Clinical Oncology.
-
February 27, 2012
A new study published online February 27, 2012 in the Journal of Clinical Oncology suggests that breast cancer survivors who were treated with a common chemotherapy regimen between 1976 and 1995 show worse cognitive performance than women of the same age who never had cancer. The differences emerged mainly in the domains of learning, memory, information processing speed and psychomotor speed. This is the first study to show that such problems, which are known to occur shortly after treatment, may also be present even 20 years after treatment.
-
February 13, 2012
Lynch syndrome is an inherited condition of cancer predisposition caused by mutations in certain genes involved in repairing DNA damage, called “mismatch repair” genes. A new study published in the Journal of Clinical Oncology provides a new, clearer picture of the cancer risks that carriers of these mutations face, which could ultimately help guide future screening efforts to detect these cancers at an early stage.
-
December 12, 2011
A large, retrospective study has shown that children of childhood cancer survivors who received prior treatment involving radiation to testes or ovaries and/or chemotherapy with alkylating agents do not have an increased risk for birth defects compared to children of survivors who did not have such cancer treatment. Radiotherapy and chemotherapy with alkylating agents are DNA-damaging treatments, affecting both cancer and healthy cells. The findings provide reassurance that increased risks of birth defects are unlikely for cancer survivors who are concerned about the potential effects of their treatment on their children, and help guide family planning choices.
-
October 31, 2011
An analysis of more than 3,000 families including women with breast cancer has found that close relatives of women who carry mutations in a BRCA gene - but who themselves do not have such genetic mutations - do not have an increased risk of developing breast cancer compared to relatives of women with breast cancer who do not have such mutations.
-
October 3, 2011
A new study has shown that rates of oropharyngeal cancer, a type of oral cancer, have been increasing dramatically in the United States since 1984, with human papillomavirus (HPV)-related tumors accounting for a growing majority of all new cases. Researchers showed that the proportion of oropharyngeal cancers that were HPV-positive significantly increased over time, from slightly more than 16 percent of such cancers diagnosed during the 1980s to more than 70 percent diagnosed during the 2000s.
-
August 29, 2011
A new study has shown that for patients with advanced rectal cancer, using magnetic resonance imaging (MRI) to assess their tumor's response to pre-surgery chemotherapy or radiation treatment may predict survival. The findings suggest that by using MRI to gauge whether a tumor has responded to such treatments, physicians can use the results to determine whether to proceed with surgery or to consider other treatment options for a given patient.
-
March 28, 2011
A new study on the use of PSA (prostate-specific antigen) testing to screen for prostate cancer found that elderly men are being screened much more frequently than men in their early fifties, even though younger men are more likely to benefit from early diagnosis and treatment. Researchers showed that men in their seventies underwent PSA screening for prostate cancer at nearly twice the rate of men in their early fifties. Men 85 and older were screened just as often.
-
March 14, 2011
A new study has shown that a surgical technique can effectively locate and extract viable sperm in more than one-third of adult survivors of childhood cancer, who were previously considered sterile due to prior chemotherapy. Many of these men were subsequently able to have children with the help of in vitro fertilization, and the results offer a proven option for many male cancer survivors who want to be fathers but were thought infertile.
-
January 31, 2011
Researchers have shown a form of personalized gene therapy that uses a patient's own immune cells could treat metastatic melanoma and synovial cell sarcoma tumors, representing a potentially new therapeutic approach against these and other cancers.
-
December 6, 2010
A study of more than 1,600 adults in Australia found that regular use of sunscreen reduced the risk of developing melanoma - the deadliest form of skin cancer - by half, including nearly three-quarters fewer cases of the more dangerous invasive type of melanoma. It is thought to be the first such randomized trial to examine the use of sunscreen in preventing melanoma.
-
November 22, 2010
An analysis of more than 3,500 children with neuroblastoma showed for the first time that blacks and Native Americans were more likely to have high-risk, aggressive disease than whites. Both groups also had worse survival - both overall and living disease-free without recurrence. In addition, neuroblastoma recurred at a higher rate in blacks compared to whites among highrisk patients who remained disease-free for two or more years after diagnosis.
-
November 15, 2010
A large Dutch study of women at increased risk for hereditary breast cancer has found that magnetic resonance imaging (MRI) was superior to mammography in early detection of tumors in women with mutations in the BRCA genes or at high risk for cancer because of family history. The study did not look at MRI as a standard screening technique for all women, but rather only those considered at risk.
-
September 13, 2010
A new study of patients dying of cancer and their caregivers has found that individuals who die in the hospital or intensive care unit have a worse quality of life at the end of their lives compared to those cancer patients who die at home with hospice services. In addition, their caregivers are more likely to develop psychiatric problems while grieving.
